With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.68 million shares. During the session, the Insurance – Life company that operates in wider Financial sector, reached to the highest price of $88.0 whereas the lowest price it dropped to was $85.91. The 52-week range on JXN shows that it touched its highest point at $115.22 and its lowest point at $64.70 during that stretch. It currently has a 1-year price target of $96.60. With its current market cap of 6.28 billion, JXN has annualized dividend of $3.00 while the current yield stands at 3.41%. JXN paid its most recent dividend on 1749686400, while the ex-dividend date for that was 1749686400. Beta for the stock currently stands at 1.48.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of JXN was down-trending over the past week, with a drop of -0.26%, but this was up by 5.85% over a month. Three-month performance surged to 24.58% while six-month performance fell -2.29%. The stock gained 0.93% in the past year, while it has gained 19.99% so far this year. A look at the trailing 12-month EPS for JXN yields 1.03 with Next year EPS estimates of 21.60. For the next quarter, that number is 4.76. This implies an EPS growth rate of 6.59% for this year and 7.87% for next year.
Float and Shares Shorts:
At present, 71.88 million JXN shares are outstanding with a float of 69.79 million shares on hand for trading. On 2025-06-13, short shares totaled 3.66 million, which was 513.0 higher than short shares on 1747267200. In addition to Ms. Laura Louene Prieskorn as the firm’s CEO, President & Director, Mr. Don Wayne Cummings serves as its Executive VP, CFO, Controller & Chief Accounting Officer.
Institutional Ownership:
Through their ownership of 0.9615 of JXN’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for JXN since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With JXN analysts setting a high price target of 108.0 and a low target of 80.0, the average target price over the next 12 months is 95.0. Based on these targets, JXN could surge 22.88% to reach the target high and fall by -8.98% to reach the target low. Reaching the average price target will result in a growth of 8.09% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $19.33226 being high and $18.70396 being low. For JXN, this leads to a yearly average estimate of $19.01811. Based on analyst estimates, the high estimate for the next quarter is $4.95 and the low estimate is $4.59. The average estimate for the next quarter is thus $4.74.
